Comparison of a real-time PCR method with serology and blood smear analysis for diagnosis of human anaplasmosis: Importance of infection time course for optimal test utilization

Journal of Clinical Microbiology

Volumn 51, Issue 7, 2013, Pages 2147-2153

  Schotthoefer, A M ^a   Meece, J K ^a   Ivacic, L C ^a   Bertz, P D ^a   Zhang, K ^a   Weiler, T ^a   Uphoff, T S ^a   Fritsche, T R ^a,b  

^a MARSHFIELD CLINIC   (United States)

^b UNIVERSITY OF WISCONSIN LA CROSSE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANAPLASMA; ANAPLASMA PHAGOCYTOPHILUM; ARTICLE; BACTERIUM DETECTION; BLOOD SMEAR; CLINICAL FEATURE; CONTROLLED STUDY; CONVALESCENCE; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DISEASE COURSE; EARLY DIAGNOSIS; EHRLICHIA; FEMALE; HUMAN; HUMAN CELL; HUMAN GRANULOCYTIC ANAPLASMOSIS; INCIDENCE; INFECTION RATE; INFECTION TIME COURSE; INTERMETHOD COMPARISON; LABORATORY TEST; LIMIT OF DETECTION; MAJOR CLINICAL STUDY; MALE; MICROBIOLOGICAL PARAMETERS; POPULATION RESEARCH; PREDICTIVE VALUE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; SEROLOGY; SPECIES DIFFERENTIATION; ADOLESCENT; AGED; ANAPLASMOSIS; CHILD; COMPARATIVE STUDY; EVALUATION STUDY; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROSCOPY; MIDDLE AGED; PRESCHOOL CHILD; PROCEDURES; TIME; VERY ELDERLY; YOUNG ADULT;

ANAPLASMA; ANAPLASMA PHAGOCYTOPHILUM; EHRLICHIA; IXODIDA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANAPLASMA PHAGOCYTOPHILUM; ANAPLASMOSIS; BACTERIOLOGICAL TECHNIQUES; CHILD; CHILD, PRESCHOOL; FEMALE; HUMANS; MALE; MICROSCOPY; MIDDLE AGED; REAL-TIME POLYMERASE CHAIN REACTION; SEROLOGIC TESTS; TIME FACTORS; YOUNG ADULT;

EID: 84879447110     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00347-13     Document Type: Article

References (34)

1. Dahlgren FS, Mandel EJ, Krebs JW, Massung RF, McQuiston JH. 2011. Increasing incidence of Ehrlichia chaffeensis and Anaplasma phagocytophilum in the United States, 2000-2007. Am. J. Trop. Med. Hyg. 85:124-131.
2. Dumler JS, Madigan JE, Pusterla N, Bakken JS. 2007. Ehrlichioses in humans: epidemiology, clinical presentation, diagnosis, and treatment. Clin. Infect. Dis. 45(Suppl 1):S45-S51. doi:10.1086/518146.
3. Thomas RJ, Dumler JS, Carlyon JA. 2009. Current management of human granulocytic anaplasmosis, human monocytic ehrlichiosis and Ehrlichia ewingii ehrlichiosis. Expert Rev. Anti Infect. Ther. 7:709-722.
4. Chapman AS, Bakken JS, Folk SM, Paddock CD, Bloch KC, Krusell A, Sexton DJ, Buckingham SC, Marshall GS, Storch GA, Dasch GA, McQuiston JH, Swerdlow DL, Dumler SJ, Nicholson WL, Walker DH, Eremeeva ME, Ohl CA, Tickborne Rickettsial Diseases Working Group, CDC. 2006. Diagnosis and management of tickborne rickettsial diseases: Rocky Mountain spotted fever, ehrlichioses, and anaplasmosis-United States: a practical guide for physicians and other health-care and public health professionals. MMWR Recomm. Rep. 55:1-27.
5. Maurin M, Abergel C, Raoult D. 2001. DNA gyrase-mediated natural resistance to fluoroquinolones in Ehrlichia spp. Antimicrob. Agents Chemother. 45:2098-2105.
6. Bakken JS, Haller I, Riddell D, Walls JJ, Dumler JS. 2002. The serological response of patients infected with the agent of human granulocytic ehrlichiosis. Clin. Infect. Dis. 34:22-27.
7. Bakken JS, Dumler JS. 2006. Clinical diagnosis and treatment of human granulocytotropic anaplasmosis. Ann. N. Y. Acad. Sci. 1078:236-247.
8. Walls JJ, Aguero-Rosenfeld M, Bakken JS, Goodman JL, Hossain D, Johnson RC, Dumler JS. 1999. Inter-and intralaboratory comparison of Ehrlichia equi and human granulocytic ehrlichiosis (HGE) agent strains for serodiagnosis of HGE by the immunofluorescent-antibody test. J. Clin. Microbiol. 37:2968-2973.
9. Comer JA, Nicholson WL, Olson JG, Childs JE. 1999. Serologic testing for human granulocytic ehrlichiosis at a national referral center. J. Clin. Microbiol. 37:558-564.
10. Comer JA, Nicholson WL, Sumner JW, Olson JG, Childs JE. 1999. Diagnosis of human ehrlichiosis by PCR assay of acute-phase serum. J. Clin. Microbiol. 37:31-34.
11. Buller RS, Arens M, Hmiel SP, Paddock CD, Sumner JW, Rikhisa Y, Unver A, Gaudreault-Keener M, Manian FA, Liddell AM, Schmulewitz N, Storch GA. 1999. Ehrlichia ewingii, a newly recognized agent of human ehrlichiosis. N. Engl. J. Med. 341:148-155.
12. Beall MJ, Alleman AR, Breitschwerdt EB, Cohn LA, Couto CG, Dryden MW, Guptill LC, Iazbik C, Kania SA, Lathan P, Little SE, Roy A, Sayler KA, Stillman BA, Welles EG, Wolfson W, Yabsley MJ. 2012. Seroprevalence of Ehrlichia canis, Ehrlichia chaffeensis and Ehrlichia ewingii in dogs in North America. Parasit. Vectors 5:29. doi:10.1186/1756-3305-5-29.
13. Dumler JS, Brouqui P. 2004. Molecular diagnosis of human granulocytic anaplasmosis. Expert Rev. Mol. Diagn. 4:559-569.
14. Edelman DC, Dumler JS. 1996. Evaluation of an improved PCR diagnostic assay for human granulocytic ehrlichiosis. Mol. Diagn. 1:41-49.
15. Bell CA, Patel R. 2005. A real-time combined polymerase chain reaction assay for the rapid detection and differentiation of Anaplasma phagocytophilum, Ehrlichia chaffeensis, and Ehrlichia ewingii. Diagn. Microbiol. Infect. Dis. 53:301-306.
16. Chen SM, Dumler JS, Bakken JS, Walker DH. 1994. Identification of a granulocytotropic Ehrlichia species as the etiologic agent of human disease. J. Clin. Microbiol. 32:589-595.
17. Centers for Disease Control and Prevention (CDC). 1995. Recommendations for test performance and interpretation from the Second National Conference on Serologic Diagnosis of Lyme Disease. MMWR Morb. Mortal. Wkly. Rep. 44:590-591.
18. Pritt BS, Sloan LM, Johnson DK, Munderloh UG, Paskewitz SM, McElroy KM, McFadden JD, Binnicker MJ, Neitzel DF, Liu G, Nicholson WL, Nelson CM, Franson JJ, Martin SA, Cunningham SA, Steward CR, Bogumill K, Bjorgaard ME, Davis JP, McQuiston JH, Warshauer DM, Wilhelm MP, Patel R, Trivedi VA, Eremeeva ME. 2011. Emergence of a new pathogenic Ehrlichia species, Wisconsin and Minnesota, 2009. N. Engl. J. Med. 365:422-429.
19. Stokes ME, Davis CS, Koch GG. 2000. Categorical data analysis using the SAS system, 2nd ed. SAS Institute Inc., Cary, NC.
20. Aguero-Rosenfeld ME. 2002. Diagnosis of human granulocytic ehrlichiosis: state of the art. Vector Borne Zoonotic Dis. 2:233-239.
21. Walker D, Task Force on Consensus Approach for Ehrlichiosis. 2000. Diagnosing human ehrlichioses: current status and recommendations. ASM News 66:287-290.
22. Bakken JS, Aguero-Rosenfeld ME, Tilden RL, Wormser GP, Horowitz HW, Raffalli JT, Baluch M, Riddell D, Walls JJ, Dumler JS. 2001. Serial measurements of hematologic counts during the active phase of human granulocytic ehrlichiosis. Clin. Infect. Dis. 32:862-870.
23. Bakken JS, Dumler JS. 2000. Human granulocytic ehrlichiosis. Clin. Infect. Dis. 31:554-560.
24. Aguero-Rosenfeld ME, Kalantarpour F, Baluch M, Horowitz HW, McKenna DF, Raffalli JT, Hsieh TC, Wu J, Dumler JS, Wormser GP. 2000. Serology of culture-confirmed cases of human granulocytic ehrlichiosis. J. Clin. Microbiol. 38:635-638.
25. Muldrew KL. 2009. Molecular diagnostics of infectious diseases. Curr. Opin. Pediatr. 21:102-111.
26. Weile J, Knabbe C. 2009. Current applications and future trends of molecular diagnostics in clinical bacteriology. Anal. Bioanal. Chem. 394: 731-742.
27. Bakken JS, Goellner P, Van Etten M, Boyle DZ, Swonger OL, Mattson S, Krueth J, Tilden RL, Asanovich K, Walls J, Dumler JS. 1998. Seroprevalence of human granulocytic ehrlichiosis among permanent residents of northwestern Wisconsin. Clin. Infect. Dis. 27:1491-1496.
28. Bakken JS, Krueth J, Wilson-Nordskog C, Tilden RL, Asanovich K, Dumler JS. 1996. Clinical and laboratory characteristics of human granulocytic ehrlichiosis. JAMA 275:199-205.
29. Dumler JS, Barat NC, Barat CE, Bakken JS. 2007. Human granulocytic anaplasmosis and macrophage activation. Clin. Infect. Dis. 45:199-204.
30. Goodman JL. 2005. Human granulocytic anaplasmosis, p 218-238. In Goodman JL, Dennis DT, Sonenshine DE (ed), Tick-borne diseases of humans. ASM Press, Washington, DC.
31. Talsness SR, Shukla SK, Mazza JJ, Yale SH. 2011. Rhabdomyolysisinduced acute kidney injury secondary to Anaplasma phagocytophilum and concomitant statin use. WMJ 110:82-84.
32. Mixson TR, Ginsberg HS, Campbell SR, Sumner JW, Paddock CD. 2004. Detection of Ehrlichia chaffeensis in adult and nymphal Amblyomma americanum (Acari: Ixodidae) ticks from Long Island, New York. J. Med. Entomol. 41:1104-1110.
33. Paddock CD, Childs JE. 2003. Ehrlichia chaffeensis: a prototypical emerging pathogen. Clin. Microbiol. Rev. 16:37-64.
34. Telford SR, III, Goethert HK, Cunningham JA. 2011. Prevalence of Ehrlichia muris in Wisconsin deer ticks collected during the mid-1990s. Open Microbiol. J. 5:18-20.